A cancer vaccine could be a reality in a few years, according to the co-founders of BioNTech, a German company, which also manufactured the...

Moderna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...

After the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...

The European Medicines Agency said it would review data, including results from an ongoing study, for the vaccine - known as Comirnaty. It ...

The research, published in The Lancet, found that antibody levels among Hong Kong health workers who have been fully vaccinated with BioNTe...

In a statement on Monday, Pfizer spokesperson said: "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-B...

Various governments, WHO and others have been pushing vaccine makers to transfer technology to companies in Asia and Africa to scale up pro...

Ugur Sahin, the chief executive of BioNTech, rejected the U.S.-backed proposal to temporarily lift some intellectual property rights for va...

BioNTech's first-quarter total revenues were 2.05 billion euros, up from 27.7 million a year earlier, inflated by the vaccine, and includin...

The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer...

The drugmaker said it was ready to pursue mRNA on its own following its experience in the past year working on the COVID-19 vaccine, the WS...

Pfizer said it had supplied 65 million doses globally and 29 million doses in the United States as of Jan. 31. It expects to supply 200 mil...

While the findings indicated no need for a new vaccine to tackle the new strains, Pfizer and BioNTech said they would respond if there was ...

Doctors in Norway have been asked to conduct more thorough evaluations of very frail elderly patients in line to receive the Pfizer-BioNTec...

Pfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The compan...

Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large s...

Britain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...